Skip to main content

Abstract

Objective:

The purpose of this study was to determine the neural correlates of excessive habit formation in obsessive-compulsive disorder (OCD). The authors aimed to test for neurobiological convergence with the known pathophysiology of OCD and to infer, based on abnormalities in brain activation, whether these habits arise from dysfunction in the goal-directed or habit system.

Method:

Thirty-seven OCD patients and 33 healthy comparison subjects learned to avoid shocks while undergoing a functional MRI scan. Following four blocks of training, the authors tested whether the avoidance response had become a habit by removing the threat of shock and measuring continued avoidance. Task-related differences in brain activity in three regions of interest (the caudate, the putamen, and the medial orbitofrontal cortex) were tested at a statistical threshold set at <0.05 (family-wise-error corrected).

Results:

Excessive habit formation in OCD patients, which was associated with hyperactivation in the caudate, was observed. Activation in this region was also associated with subjective ratings of increased urge to perform habits. The OCD group, as a whole, showed hyperactivation in the medial orbitofrontal cortex during the acquisition of avoidance; however, this did not relate directly to habit formation.

Conclusions:

OCD patients exhibited excessive habits that were associated with hyperactivation in a key region implicated in the pathophysiology of OCD, the caudate nucleus. Previous studies indicate that this region is important for goal-directed behavior, suggesting that habit-forming biases in OCD may be a result of impairments in this system, rather than differences in the buildup of stimulus-response habits themselves.

Formats available

You can view the full content in the following formats:

Supplementary Material

File (appi.ajp.2014.14040525.ds001.pdf)

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 284 - 293
PubMed: 25526600

History

Received: 24 April 2014
Revision received: 20 June 2014
Revision received: 30 July 2014
Accepted: 29 August 2014
Published online: 19 December 2014
Published in print: March 01, 2015

Authors

Affiliations

Claire M. Gillan, Ph.D.
From the Departments of Psychology and Psychiatry, and the Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom; the Department of Psychology at New York University, New York; South Essex Partnership University NHS Foundation Trust, Springhouse, Biggleswade Hospital, Bedfordshire, United Kingdom; the Department of Psychiatry, Queen Elizabeth II Hospital, Welwyn Garden City, Hertfordshire, United Kingdom; and the Postgraduate Medical School, University of Hertfordshire, Hatfield, United Kingdom.
Annemieke M. Apergis-Schoute, Ph.D.
From the Departments of Psychology and Psychiatry, and the Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom; the Department of Psychology at New York University, New York; South Essex Partnership University NHS Foundation Trust, Springhouse, Biggleswade Hospital, Bedfordshire, United Kingdom; the Department of Psychiatry, Queen Elizabeth II Hospital, Welwyn Garden City, Hertfordshire, United Kingdom; and the Postgraduate Medical School, University of Hertfordshire, Hatfield, United Kingdom.
Sharon Morein-Zamir, Ph.D.
From the Departments of Psychology and Psychiatry, and the Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom; the Department of Psychology at New York University, New York; South Essex Partnership University NHS Foundation Trust, Springhouse, Biggleswade Hospital, Bedfordshire, United Kingdom; the Department of Psychiatry, Queen Elizabeth II Hospital, Welwyn Garden City, Hertfordshire, United Kingdom; and the Postgraduate Medical School, University of Hertfordshire, Hatfield, United Kingdom.
Gonzalo P. Urcelay, Ph.D.
From the Departments of Psychology and Psychiatry, and the Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom; the Department of Psychology at New York University, New York; South Essex Partnership University NHS Foundation Trust, Springhouse, Biggleswade Hospital, Bedfordshire, United Kingdom; the Department of Psychiatry, Queen Elizabeth II Hospital, Welwyn Garden City, Hertfordshire, United Kingdom; and the Postgraduate Medical School, University of Hertfordshire, Hatfield, United Kingdom.
Akeem Sule, M.B.B.S., M.R.C.Psych.
From the Departments of Psychology and Psychiatry, and the Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom; the Department of Psychology at New York University, New York; South Essex Partnership University NHS Foundation Trust, Springhouse, Biggleswade Hospital, Bedfordshire, United Kingdom; the Department of Psychiatry, Queen Elizabeth II Hospital, Welwyn Garden City, Hertfordshire, United Kingdom; and the Postgraduate Medical School, University of Hertfordshire, Hatfield, United Kingdom.
Naomi A. Fineberg, M.A., M.R.C.Psych.
From the Departments of Psychology and Psychiatry, and the Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom; the Department of Psychology at New York University, New York; South Essex Partnership University NHS Foundation Trust, Springhouse, Biggleswade Hospital, Bedfordshire, United Kingdom; the Department of Psychiatry, Queen Elizabeth II Hospital, Welwyn Garden City, Hertfordshire, United Kingdom; and the Postgraduate Medical School, University of Hertfordshire, Hatfield, United Kingdom.
Barbara J. Sahakian, Ph.D.
From the Departments of Psychology and Psychiatry, and the Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom; the Department of Psychology at New York University, New York; South Essex Partnership University NHS Foundation Trust, Springhouse, Biggleswade Hospital, Bedfordshire, United Kingdom; the Department of Psychiatry, Queen Elizabeth II Hospital, Welwyn Garden City, Hertfordshire, United Kingdom; and the Postgraduate Medical School, University of Hertfordshire, Hatfield, United Kingdom.
Trevor W. Robbins, Ph.D.
From the Departments of Psychology and Psychiatry, and the Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom; the Department of Psychology at New York University, New York; South Essex Partnership University NHS Foundation Trust, Springhouse, Biggleswade Hospital, Bedfordshire, United Kingdom; the Department of Psychiatry, Queen Elizabeth II Hospital, Welwyn Garden City, Hertfordshire, United Kingdom; and the Postgraduate Medical School, University of Hertfordshire, Hatfield, United Kingdom.

Notes

Address correspondence to Dr. Gillan ([email protected]).

Funding Information

Wellcome Trust10.13039/100004440: 089589/Z/09/Z, 101521/Z/13/Z, G00001354
Medical Research Council10.13039/501100000265: G00001354
Supported by a Sir Henry Wellcome Postdoctoral Fellowship (101521/Z/12/Z) to Dr. Gillan and by Wellcome Trust grant (089589/Z/09/Z) to Drs. Sahakian and Robbins. This study was completed at the Behavioural and Clinical Neuroscience Institute, which is supported by a joint award from the Medical Research Council and Wellcome Trust (G00001354).Dr. Fineberg has served as a consultant for GlaxoSmithKline, Lundbeck, Novartis, Servier, and Transcept; has received research support from AstraZeneca, Cephalon, the European College of Neuropsychopharmacology, GlaxoSmithKline, Lundbeck, Servier, the United Kingdom Medical Research Council, the United Kingdom National Institute for Health Research, and the Wellcome Foundation; has received honoraria for lectures at scientific meetings from AstraZeneca, Bristol-Myers Squibb, Jazz Pharmaceuticals, Lundbeck, and Servier; and has received financial support to attend scientific meetings from BAP Pharma, Bristol-Myers Squibb, Cephalon, the European College of Neuropsychopharmacology, Janssen, Lundbeck, Novartis, the International College of Obsessive Compulsive Spectrum Disorders, the International Society for Addiction, the Royal College of Psychiatrists, Servier, and the World Health Organization. Dr. Sahakian has served as a consultant for Boehringer-Ingelheim, Cambridge Cognition, Eli Lilly, GlaxoSmithKline, Novartis, Otsuka, and Shire; has received honoraria for Grand Rounds in Psychiatry at Massachusetts General Hospital (CME credits) and for speaking at the International Conference on Cognitive Dysfunction in Schizophrenia and Mood Disorders; has served on the Medical Research Council Neurosciences and Mental Health Board and on the Science Coordination Team for the Foresight Project on Mental Capital and Wellbeing; has served on Panel LS5 for the European Research Council; and receives an honorarium from the Journal of Psychological Medicine. Dr. Robbins has served as a consultant for Cambridge Cognition, Eli Lilly, Lundbeck, Shire Pharmaceuticals, and Teva; has received research grants from Eli Lilly, GlaxoSmithKline, and Lundbeck; has received editorial honoraria from Elsevier and Springer-Verlag; has received educational lecture fees from Dohme, Merck, and Sharp; and receives royalties from Cambridge Cognition. All other authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share